VLA 0.00% $1.75 viralytics limited

The point is that VLA have the patent which covers the right to...

  1. 1,482 Posts.
    The point is that VLA have the patent which covers the right to use EVATAKTM (The trademarked name of Viralytics proprietary formulation of the Echovirus Type 1) in conjunction with other oncolytic virusessuch as the Companys lead product CAVATAKTM.
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.